NewLimit, founded by Coinbase CEO Brian Armstrong, raises $130M to develop age-reversing treatments

NeolumA startup that noticed that people genet their cells can lead to a healthy life by programming, raising a $ 130 million series B led by Claine Parkins.

New investor Nat Fredman, Daniel Gross and Khosla Ventures have also invested, as back to the Backs Foundation Fund, DimensionsElalad Gill, Gary Tan, Patrick Collison and others. The company comes to fund the fund two years after raising $ 40 million series AThe

Four years ago, Cinbase CEO Brian Armstrong (depicted above), former GV partner Blake Bowers and Stem Cell Professor Jacob Kimmel, claimed that it made significant progress towards developing treatment that could restore youth in older cells.

Kimel told TechCrunch that the company has invented three prototype drugs that re -program liver cells. He said that the lab tests in Neulmet -display the audiences, this revival can recover the capacity of fat and alcohol processing cells.

The company measures its progress in contrast to how the cells react to the substances from young people and older people. Kimmel said an old liver cell that passed through the epignetic repurchase of Neulmet was behaved like another small cell, Kimel said.

Despite the promise of the initial results, the neolithic human trial is a few years away from the beginning.

In the meantime, the company wants to continue to develop new anti-aging medicine using the AI ​​model and then do the most committed tests of these machine-made drugs in its laboratory. Kimel said, “What lets the AI ​​model allow us to do is conduct all these tests in simulations and then followed only in the most committed subset,” Kimmel added that the AI ​​model is used to re -training in a process known as “Loop Lab”.

Other noticeable biotech startups developed drugs that aims to increase lifetime include Retro Biosiens, which two years ago collected $ 180 million from OpenAI chief executive officer Sam Altman and raising it a At $ 1 billion series; And the Labs of Ultos, which Opened With $ 3 billion in 2022 and supported by Jeff Bezos.